Current Headlines

  1. World Courier’s CORE Labs Uses Data And Innovation To Improve Pharmaceutical Supply Chain Effectiveness

    World Courier, the global leader in specialty logistics and an AmerisourceBergen company, has announced the launch of its Climate Optimisation Research & Engineering (CORE) Labs. Science-led and data-driven, CORE Labs is a new solutions center within World Courier focused solely on helping pharmaceutical manufacturer clients evaluate, validate and select the right climate-controlled packaging solutions for their specific needs.

  2. Innova Biosciences Introduces Range Of Conjugated Antibodies

    Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, announced recently the launch of a range of conjugated antibodies.

  3. Global Vision Announces The Release Of New Technology For PDF-To-Print Inspection

    Global Vision, the world leader in the development of innovative proofreading technologies, recently announced the release of version 3.0.0 of its award winning print inspection solution, ScanProof.

  4. BioOutsource Opens New Facility In Glasgow

    BioOutsource Ltd. (“BioOutsource”), part of Sartorius Stedim Biotech Group and a global leader in biologics contract testing and biosimilar characterisation for the biopharmaceutical industry, recently announced the opening of a new facility which doubles Biooutsource’s capacity for future growth.

  5. 3SBio Acquires Zhejiang Wansheng Pharmaceutical

    3SBio Inc., (HKEX:1530) ("3SBio" or 'the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the entire equity interest in Zhejiang Wansheng Pharmaceutical Co., Ltd ("Zhejiang Wansheng") a limited liability company incorporated in the PRC for an aggregate consideration of RMB 528 million.

  6. Lysogene and Alcyone Lifesciences Enter a Collaboration for Mucopolysaccharidosis Type IIIA (MPS IIIA)

    Lysogene and Alcyone Lifesciences enter into a collaboration for mucopolysaccharidosis type IIIA (MPS IIIA). The collaboration combines the companies’ expertise in proprietary recombinant adeno-associated virus (rAAV) based gene therapy and MEMS based targeted drug delivery

  7. Grace Introduces DARACLAR 9000HP, New Beer Stabilizer That Increases Productivity, Reduces Environmental Impact

    W. R. Grace & Co. (NYSE: GRA) announces a breakthrough in beer stabilization that increases brewing productivity while decreasing the amount of water used and solid waste created in the brewing process.

  8. Clever FlexiBulk Tip Packs – Save Space and Effort in Your Lab

    Sartorius Stedim Biotech (SSB), a leading international laboratory and pharmaceutical supplier, introduces a completely new concept for packaging pipette tips: FlexiBulk. 

  9. IRESSA (gefitinib) Approved By The U.S. Food And Drug Administration For First-Line Treatment Of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer

    AstraZeneca recently announced that the U.S. Food and Drug Administration (FDA) has approved IRESSA (gefitinib) as a first-line treatment in patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

  10. Save Time And Costs With The All-New PROPOR TFF Filter Range

    PROPOR TFF, Parker domnick hunter’s new range of hollow fibre tangential flow filters, offers a number of benefits for microfiltration and ultrafiltration applications in the biopharmaceutical industry.